Michiko Hamada

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Hyaluronic Acid

Top Venues

Reproductive medicine and biology

This page only lists publications with an associated author ORCID identifier.

Publications

Rena Toriumi, Michiharu Horikawa, Chie Sato, Nagisa Shimamura, Rena Ishii, Michiru Terashima, Michiko Hamada, Naoyuki Tachibana, Yuji Taketani
The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT-FET cycles. Reproductive medicine and biology 22 (1) (2023)
Rena Toriumi, Michiharu Horikawa, Chie Sato, Nagisa Shimamura, Rena Ishii, Michiru Terashima, Michiko Hamada, Naoyuki Tachibana, Yuji Taketani
The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT-FET cycles. Reproductive medicine and biology 22 (1) (2023)
Michiko Hamada, Michiharu Horikawa, Chie Ensaka, Megumi Enomoto, Rena Ishii, Rena Toriumi, Naoyuki Tachibana, Yuji Taketani
A novel orally active gonadotropin-releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology. Reproductive medicine and biology 21 (1) (2021)